AI Maverick Intel, Inc., formerly known as Bionoid Pharma, Inc., has confirmed a name change following approval from the State of Delaware. The company is in the process of updating its name and trading symbol on the OTC Markets, pending FINRA's approval. This change aligns with the company's strategic focus on leveraging artificial intelligence to expand and innovate within technology-driven sectors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.